News
Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.
- Shorted shortlist? Fewer pharmas make the cut for Lions Health finals
- Merck, Lilly and Amgen sue HHS to thwart rule requiring list prices in TV ads
- Unum Therapeutics Appoints Jessica Sachs Chief Medical Officer
- Flatiron Taps Vasoncelles of Unum Therapeutics for Chief Medical Officer
- Amgen, Merck, and Eli Lilly sue over Trump administration policy to require drug prices in TV ads
- STAT Plus: Architects of a new CRISPR partnership defend academic-industry research model
- Despite late-stage win, investors not sold on Global Blood sickle cell drug
- After Ebola spills into Uganda, WHO decides against emergency declaration
- Bluebird Bio Sets $1.8M Price on Gene Therapy for Rare Blood Disease
- Upadacitinib a plus for AbbVie in rheumatoid arthritis, doc survey says
- Bluebird sets $1.8M price tag for blood-disease gene therapy
- STAT Plus: Up and down the ladder: the latest comings and goings
- BIO: Jeremy Levin and John Maraganore reflect on drug pricing and innovation
- Lions Health Preview: 2019 attendees scouting for edgy tech, new ideas and a little respect
- STAT Plus: Facing progressive pressure, Pelosi could expand her drug pricing plan to negotiate prices for $118 billion worth of medicines